Cargando…

Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats

BACKGROUND: The present investigation was aimed at evaluating the hypoglycemic and hypolipidemic properties of the aqueous and methanolic extracts from Bersama engleriana leaves in streptozotocin/nicotinamide (STZ-NA)-induced type 2 diabetic rats. METHODS: Animals were orally treated for 4 consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierre, Watcho, Gildas, Achountsa Jeugo Hugues, Ulrich, Mbiakop Carlos, Modeste, Wankeu-Nya, Benoît, Nguelefack Télesphore, Albert, Kamanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546073/
https://www.ncbi.nlm.nih.gov/pubmed/23267560
http://dx.doi.org/10.1186/1472-6882-12-264
_version_ 1782255995850850304
author Pierre, Watcho
Gildas, Achountsa Jeugo Hugues
Ulrich, Mbiakop Carlos
Modeste, Wankeu-Nya
Benoît, Nguelefack Télesphore
Albert, Kamanyi
author_facet Pierre, Watcho
Gildas, Achountsa Jeugo Hugues
Ulrich, Mbiakop Carlos
Modeste, Wankeu-Nya
Benoît, Nguelefack Télesphore
Albert, Kamanyi
author_sort Pierre, Watcho
collection PubMed
description BACKGROUND: The present investigation was aimed at evaluating the hypoglycemic and hypolipidemic properties of the aqueous and methanolic extracts from Bersama engleriana leaves in streptozotocin/nicotinamide (STZ-NA)-induced type 2 diabetic rats. METHODS: Animals were orally treated for 4 consecutive weeks with Bersama engleriana extracts at doses of 300 or 600 mg/kg. The anti-diabetic effect was examined by measuring blood glucose (BG) at 0, 1, 14 and 28 days after STZ-NA treatment and, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) levels at sacrifice (day 29). Glibenclamide (0.25 mg/kg) was used for comparison. RESULTS: STZ-NA-induced diabetic rats showed moderate to significant increases in the levels of BG, TG, TC, LDL-C while body weight, HDL-C levels and relative weights of liver and pancreas were decreased compared to controls (non diabetic rats). Administration of the plant extracts to STZ-NA diabetic rats resulted in a significant decrease in BG, TG, TC and LDL-C and the dose 600 mg/kg of the methanolic extract was the most effective; HDL-C level was markedly increased after four weeks compared to untreated diabetic rats. A dose-dependent increase in the relative weights of the diabetogenic organs was observed in the Bersama engleriana groups. It can be also noticed that the methanolic extract, especially the dose 600 mg/kg (p<0.001), produced more effects than glibenclamide and aqueous extract. Rats treated with glibenclamide (0.25 mg/kg) generally gave lower results compared to groups treated with plant extracts. CONCLUSION: Results of the present study showed that Bersama engleriana extracts and especially its methanolic extract possess antidiabetogenic properties and beneficial effects on diabetic hyperlipidemia. All these effects could be due to the bioactive components revealed in the Bersama engleriana extracts such as triterpenes and phenols and which could justify its ethnomedical use.
format Online
Article
Text
id pubmed-3546073
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35460732013-01-17 Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats Pierre, Watcho Gildas, Achountsa Jeugo Hugues Ulrich, Mbiakop Carlos Modeste, Wankeu-Nya Benoît, Nguelefack Télesphore Albert, Kamanyi BMC Complement Altern Med Research Article BACKGROUND: The present investigation was aimed at evaluating the hypoglycemic and hypolipidemic properties of the aqueous and methanolic extracts from Bersama engleriana leaves in streptozotocin/nicotinamide (STZ-NA)-induced type 2 diabetic rats. METHODS: Animals were orally treated for 4 consecutive weeks with Bersama engleriana extracts at doses of 300 or 600 mg/kg. The anti-diabetic effect was examined by measuring blood glucose (BG) at 0, 1, 14 and 28 days after STZ-NA treatment and, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) levels at sacrifice (day 29). Glibenclamide (0.25 mg/kg) was used for comparison. RESULTS: STZ-NA-induced diabetic rats showed moderate to significant increases in the levels of BG, TG, TC, LDL-C while body weight, HDL-C levels and relative weights of liver and pancreas were decreased compared to controls (non diabetic rats). Administration of the plant extracts to STZ-NA diabetic rats resulted in a significant decrease in BG, TG, TC and LDL-C and the dose 600 mg/kg of the methanolic extract was the most effective; HDL-C level was markedly increased after four weeks compared to untreated diabetic rats. A dose-dependent increase in the relative weights of the diabetogenic organs was observed in the Bersama engleriana groups. It can be also noticed that the methanolic extract, especially the dose 600 mg/kg (p<0.001), produced more effects than glibenclamide and aqueous extract. Rats treated with glibenclamide (0.25 mg/kg) generally gave lower results compared to groups treated with plant extracts. CONCLUSION: Results of the present study showed that Bersama engleriana extracts and especially its methanolic extract possess antidiabetogenic properties and beneficial effects on diabetic hyperlipidemia. All these effects could be due to the bioactive components revealed in the Bersama engleriana extracts such as triterpenes and phenols and which could justify its ethnomedical use. BioMed Central 2012-12-26 /pmc/articles/PMC3546073/ /pubmed/23267560 http://dx.doi.org/10.1186/1472-6882-12-264 Text en Copyright ©2012 Watcho et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pierre, Watcho
Gildas, Achountsa Jeugo Hugues
Ulrich, Mbiakop Carlos
Modeste, Wankeu-Nya
Benoît, Nguelefack Télesphore
Albert, Kamanyi
Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title_full Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title_fullStr Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title_full_unstemmed Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title_short Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
title_sort hypoglycemic and hypolipidemic effects of bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546073/
https://www.ncbi.nlm.nih.gov/pubmed/23267560
http://dx.doi.org/10.1186/1472-6882-12-264
work_keys_str_mv AT pierrewatcho hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats
AT gildasachountsajeugohugues hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats
AT ulrichmbiakopcarlos hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats
AT modestewankeunya hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats
AT benoitnguelefacktelesphore hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats
AT albertkamanyi hypoglycemicandhypolipidemiceffectsofbersamaenglerianaleavesinnicotinamidestreptozotocininducedtype2diabeticrats